title: Managing HIV. Part 2. Phases of disease. 2.3 HIV and intermediate immune deficiency.
abstract: Intermediate immune deficiency is defined by a CD4 cell count between 500/microL and 200/microL. This phase is one of increasing therapeutic intervention, mostly for minor infections of skin and mucous membranes and mostly manageable within general practice. Most people with HIV begin antiretroviral therapy during this phase. Regular monitoring of CD4 cell count is essential for making appropriate therapeutic decisions and for determining prognosis.
authors.affiliation: Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW.
authors.forename: S
authors.initials: S
authors.lastname: Adelstein
authors.forename: I
authors.initials: I
authors.lastname: McKnight
authors.forename: A M
authors.initials: AM
authors.lastname: Pethebridge
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D015510:Clinical Medicine; D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D008875:Middle Aged
chemical_list: D000998:Antiviral Agents